Obesity management needs medications on PBS: RACGP The college’s new obesity position statement calls for extra funding to treat the complex condition and for care to be made affordable for more patients.
Blood test shows promise for birth risk early detection A new rapid sensor test can detect pregnancy complications such as gestational diabetes and preeclampsia, as early as 11 weeks.
Wegovy approved for cutting cardiovascular disease risk The TGA has approved semaglutide (sold as Wegovy) as an adjunct to standard of care therapy to reduce the risk of major adverse cardiovascular events in overweight and obese adults.
World experts urge overhaul of obesity definition The Global Commission on Clinical Obesity says diagnosis must change, setting out new criteria, categories, and calling on doctors to go ‘beyond BMI’.
Mounjaro expanded to include weight management The TGA has approved tirzepatide for the treatment of overweight and obesity for those with comorbidities, via private prescription.
Study links semaglutide and suicidal ideation risk There are calls for urgent investigation into its impact on mental health, but GPs are urging caution when interpreting the research.
List of dementia risk factors grows The addition of untreated vision loss and high LDL cholesterol have bumped up the number of modifiable risk factors to 14.
Wegovy launches in Australia The manufacturer assured GPs supply planning has been its priority amid critical Ozempic shortages, but concerns remain over Wegovy’s availability.
Pregnancy diet could improve child’s heart health: Study Researchers found eating a high-fibre diet while pregnant may reduce the child’s CVD risk, but one GP expert says it is too early to tell.
GPs protest scrapped pregnancy counselling exemption The RACGP urged the Government to reverse the removal, saying it limits access to care and creates ‘reproductive healthcare deserts’.